A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19
Clinical trial NCT05097053 · UNKNOWN
Trial details
- NCT number
- NCT05097053
- Sponsor
- Taoyuan General Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-07
- Primary completion
- 2022-03-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.